Health Condition 1: M278- Other specified diseases of jaws
Conditions
Interventions
Intervention1: occlusal splint.
: Material: A 3 mm hard plaque resin splint was used..
Adjusted for simultaneous and equal contact of all teeth.
Patients were instructed to use it at night during
Sponsors
Reena
Eligibility
Inclusion criteria
Inclusion criteria: Presence of myofascial pain according to DC/TMD diagnostic decision tree Myofascial pain persisting for more than 3 months No medical or surgical treatment for TMD No history of OS treatment No history of masticatory muscle injection or dry needling. Absence of active caries and pulpal lesions No missing teeth other than the third molar
Exclusion criteria
Exclusion criteria: Being treated for rheumatological and neurological disorders and/or neuropathic pain and/or headache Odontogenic or nonodontogenic pathologies that may cause pain near the region of the temporomandibular joint Neuropathic pain (e.g. trigeminal neuralgia) Having a history of trauma in the head and neck region in the last 2 years Presence of malignancy or having undergone head and neck radiotherapy/chemotherapy in the last 2 years Having drug and/or alcohol addiction Having a known psychiatric disorder and using antidepressants in the last 6 months Being under active orthodontic treatment Pregnancy or lactation Having atypical fascial pain and presence of fibromyalgia Presence of active infection in the masseter TP area Being in the mixed dentition period or using of complete dentures Presence of congenital head and neck deformity Allergy to local anesthetics Acute trauma or infections that affected temporomandibular joint Systemic disorders that may affect temporomandibular joint (e.g. rheumatoid arthritis) Presence of bleeding disorder, cardiovascular disease, thyroid disease, diabetes, hypertension, renal failure, isolated muscle disease and systemic disorders that may affect the absorption mechanism of local anesthetics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| GROUP-A Receiving occlusal splint. GROUP-B Receiving trigger point wet needling with local anesthesia injection. GROUP-C Receiving trigger point Dry needling SUBJECTIVE ASSESSMENT Assessment of pain using VAS(0-10). OBJECTIVE ASSESSMENT Painless Maximum mouth opening Painless lateral and protrusive Timepoint: patients using occlusal splint were instructed to use it at night during sleep for three month with every month follow up Injections (wet needling with local anesthesia and dry needling) were repeated 3 times over a short period, with a 1-week interval (on the 7th and 14th days) and observed for 3 months for any symptoms | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactReena
TAMIL NADU GOVERNMENT DENTAL COLLEGE AND HOSPITAL CHENNAI
Outcome results
None listed